Companies / Context Therapeutics Inc.

Context Therapeutics Inc.

Nasdaq: CNTXCIK 1842952PHILADELPHIA, PA

Financials

Revenue—
Net income$-36.12M
Total debt—
Cash$42.99M
Diluted EPS$-0.38
Shares outstanding91.9M

Ownership

91.9M shares outstanding · as of Aug 3, 2026
16.7%10%+ / strategic
Ownership
10%+ / strategic16.72%15,363,102
Institutions61.64%56,636,874
Public float21.64%19,879,201

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Chagin Karen DeborahChief Medical Officer
——
Lehr Martin A.CEOChief Executive Officer · Director
——
Levit Alex C.Chief Legal Officer, Corp. Sec
——
Minai-Azary Jennifer LynnChief Financial Officer
——
Stacey Jennifer EvansDirector
——

Institutional holders 48

View all →
HolderValue% of shares
MPM BioImpact LLC$15.70M11.62%
Blue Owl Capital Holdings LP$10.93M8.09%
Nextech Invest, Ltd.$10.91M8.08%
Deep Track Capital, LP$10.91M8.08%
Avidity Partners Management LP$8.09M5.99%
Marshall Wace, LLP$7.72M3.21%
Franklin Resources, Inc.$5.88M4.36%
Great Point Partners, LLC$5.86M2.44%
Vanguard Group Inc$5.57M4.12%
Millennium Management LLC$3.73M1.55%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 24, 2026Stacey Jennifer Evans
Director
GrantStock Option (right to buy)—+45K
45,000
0.05% of shares
low
Feb 19, 2026Minai-Azary Jennifer Lynn
Executive
GrantStock Option (right to buy)—+275K
275,000
0.30% of shares
low
Feb 19, 2026Levit Alex C.
Executive
GrantStock Option (right to buy)—+270K
270,000
0.29% of shares
low
Feb 19, 2026Chagin Karen Deborah
Executive
GrantStock Option (right to buy)—+290K
290,000
0.32% of shares
low
Feb 19, 2026Lehr Martin A.
CEO
GrantStock Option (right to buy)—+815K
815,000
0.89% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Great Point Partners, LLCPassive13G/A—4,683,711—
MPM BioImpact LLCPassive13G/A—10,679,391—
Soleus Capital Master Fund, L.P.Passive13G———
Great Point Partners, LLCPassive13G/A—2,238,496—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CNTX——21077P108—